Overexpression of functional human FLT3 ligand in Pichia pastoris


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Growth factors and cytokines including FLT3 Ligand (FLT3L) have many applications in cellular and molecular biology studies, and also as therapeutical agents. FLT3L was expressed in Pichia pastoris through cloning from human leukemic K562 cell line as well as using a codon-optimized synthetic construct. Codon adaptation index (CAI) was increased from 55 in the native sequence up to 95 after optimization. Significant changes occurred in the codons for Pro, Arg, Leu and Ser toward the favored codons in P. pastoris. Both forms of expressed FLT3L (from the native and optimized sequences) were capable of stimulating proliferation of the FDC-P1 cells expressing human wild-type FLT3 (FD–FLT3–WT). Sequence optimization resulted in 55-fold increase in the yield of active FLT3L (290 μg/mL of product in the crude supernatant). Amino acid residues 27–162 are sufficient for the biological function of human FLT3L. Pichia pastoris is a highly efficient and cost-effective system for expression of endotoxin-free FLT3L; however, codon optimization is necessary for its optimal expression.

About the authors

E. Karimi

Department of Medical Biochemistry, School of Medicine

Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad

H. Faraji

Department of Medical Biotechnology, School of Medicine; Department of Laboratory Sciences, Faculty of Paramedicine

Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad; Bandar Abbas

D. Hamidi Alamdari

Department of Medical Biochemistry, School of Medicine

Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad

M. Souktanloo

Department of Medical Biochemistry, School of Medicine

Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad

M. Mojarrad

Department of Medical Genetics, School of Medicine

Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad

L. K. Ashman

Department of Medical Biochemistry, School of Biomedical Sciences and Pharmacy

Email: mashkaniba@mums.ac.ir
Australia, Callaghan, NSW, 2308

B. Mashkani

Department of Medical Biochemistry, School of Medicine; Department of Medical Biochemistry, School of Biomedical Sciences and Pharmacy

Author for correspondence.
Email: mashkaniba@mums.ac.ir
Iran, Islamic Republic of, Mashhad; Callaghan, NSW, 2308

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Inc.